Skip to main content

Lupus (Systemic Lupus Erythematosus) and cannabis in Iowa

The state currently does not list this condition as qualifying, and the program does not provide open-ended physician discretion to add conditions. Verify with the state regulator, because programs change.

Not on the qualifying list
✗ No
LEGAL
Capped at 4.5 grams THC…
POSSESSION
$100/yr
STATE FEE
7–21 d
TIMELINE
Not on the qualifying list. The state currently does not list this condition as qualifying, and the program does not provide open-ended physician discretion to add conditions. Verify with the state regulator, because programs change.

Iowa statute and program

The Iowa Medical Cannabidiol Program is the operating authority for Iowa patient certification. The authoritative legal text is: Iowa Code Chapter 124E: Medical Cannabidiol Act.

What the evidence says about cannabis and Lupus (Systemic Lupus Erythematosus)

Systemic lupus erythematosus (SLE), commonly called lupus, is a chronic autoimmune disease in which the immune system produces autoantibodies that attack the body's own tissues. Inflammation can affect joints, skin, kidneys, blood, lungs, heart, and the nervous system. Lupus is a relapsing-remitting disease — patients experience flares and periods of relative quiescence.

For the full evidence base, including the NASEM tier, randomized trial summaries, and symptom-domain breakdown, read the mmjnow Lupus (Systemic Lupus Erythematosus) page.

How to qualify in Iowa

The Iowa Medical Cannabidiol Program requires the following registration steps for a Lupus (Systemic Lupus Erythematosus) patient (or any qualifying diagnosis):

  1. Get a healthcare-practitioner certification from an Iowa-licensed provider. Under the Iowa Medical Cannabidiol Act (Iowa Code Ch. 124E), any Iowa-licensed physician, advanced registered nurse practitioner, physician assistant, or podiatrist may certify a patient for one of the enumerated debilitating medical conditions: cancer, MS, seizures, Crohn’s, AIDS or HIV, ALS, Parkinson’s, intractable autism, untreatable pain, ulcerative colitis, severe and chronic PTSD, or any terminal illness with a life expectancy of one year or less.
  2. Apply through the Iowa HHS Office of Medical Cannabidiol portal. The patient submits the Healthcare Practitioner Certification and the Patient Application through the Iowa Department of Health and Human Services (HHS) Office of Medical Cannabidiol online portal, uploads an Iowa driver license or state ID, and pays the registration fee.
  3. Pay the $100 state registration fee (or $25 reduced fee). The annual Iowa medical cannabidiol registration card fee is $100, reduced to $25 for patients enrolled in Medicaid, hawk-i, the Family Investment Program, or who have demonstrated household income at or below 200% of the federal poverty level. Caregivers register separately at the same fee structure.
  4. Receive the card and purchase from an Iowa medical cannabidiol dispensary. Iowa medical cannabidiol registration cards are issued within roughly 15 business days of complete application. With the card, patients may purchase capped doses (currently 4.5 grams of THC per 90-day rolling period under §124E.2A) from any of the licensed Iowa medical cannabidiol dispensaries. Permitted forms include capsules, tinctures, topicals, vape products, and sublinguals (no smokable flower under Ch. 124E). Iowa does not honor out-of-state medical cards.
State registration fee
$100
Physician visit (typical)
$150–$300
Certification to card
7–21 days
Out-of-state patients
Not eligible
Minors
Eligible with caregiver

For full Iowa registration steps, fees, and reciprocity rules, see the Iowa cannabis-laws page.

ICD-10 code

A certifying physician documenting Lupus (Systemic Lupus Erythematosus) for the Iowa medical cannabis program will typically record ICD-10 M32.9 or SNOMED-CT 55464009 in the patient's record. The state registry does not itself collect ICD-10 codes in most programs, but the physician's chart is the audit trail if the certification is later reviewed.

Frequently asked questions

Does Iowa list Lupus (Systemic Lupus Erythematosus) as a qualifying condition for medical cannabis?

No. Iowa's qualifying-condition list does not currently include Lupus (Systemic Lupus Erythematosus), and the state's program does not give physicians open-ended discretion to add conditions outside the list. Patients with Lupus (Systemic Lupus Erythematosus) in Iowa have limited in-state pathways under the medical program as written. Options to verify and pursue include: petitioning the state regulator to add the condition (where the statute permits public petitions); consulting a physician about whether a co-occurring listed condition could support certification; or reviewing whether the state's program is undergoing legislative expansion. Iowa program rules change, so verify the current list with the regulator before drawing a final conclusion.

How do I get a Iowa medical marijuana card for Lupus (Systemic Lupus Erythematosus)?

Because Iowa does not currently list Lupus (Systemic Lupus Erythematosus) as a qualifying condition, a card for Lupus (Systemic Lupus Erythematosus) alone may not be obtainable in-state under the program rules as written. Step one is finding a physician licensed in Iowa who is registered with Iowa Medical Cannabidiol Program and willing to evaluate Lupus (Systemic Lupus Erythematosus) cases. Step two is collecting your records (diagnosis documentation, treatment history, and the ICD-10 code your physician will use) and bringing them to the certification visit. Step three is the physician's certification through the state registry, followed by the patient registration application, state fee, and waiting period before the card is issued. Iowa does not honor out-of-state cards, so the certification process has to originate inside the state. Verify the patient minimum age with the state program before applying. Confirm the current process with the state regulator before applying, because the rules change.

What does the evidence say about cannabis for Lupus (Systemic Lupus Erythematosus)?

For Lupus (Systemic Lupus Erythematosus), evidence is described as limited (a small number of supportive studies, often underpowered or focused on narrow symptom domains). The mmjnow condition page for Lupus (Systemic Lupus Erythematosus) lays out the current evidence base, including the citations underlying that evidence tier — typically the National Academies of Sciences, Engineering, and Medicine consensus reports, federal agency guidance, and peer-reviewed reviews. Evidence quality is independent of state law: a state can list a condition for which evidence is limited, and a state can decline to list a condition for which evidence is strong. Patients deciding whether to pursue medical cannabis for Lupus (Systemic Lupus Erythematosus) should review the underlying evidence (linked on the condition page) and discuss expected benefit, dosing, and risk with a clinician familiar with both Lupus (Systemic Lupus Erythematosus) and cannabinoid pharmacology. Cannabis is not a substitute for evidence-based first-line treatments for Lupus (Systemic Lupus Erythematosus); the evidence position above describes whether trial data supports its use, not whether it should replace standard care.

Sources

  1. Iowa Code Chapter 124E: Medical Cannabidiol Actaccessed May 16, 2026
  2. Iowa Department of Health and Human Services: Office of Medical Cannabidiolaccessed May 16, 2026
  3. Wikipedia: Cannabis in Iowaaccessed May 16, 2026
  4. NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases: Lupusaccessed May 18, 2026
  5. NASEM: The Health Effects of Cannabis and Cannabinoids (2017)accessed May 18, 2026

    “Substantial evidence that cannabis or cannabinoids are effective for chronic pain in adults.”

  6. Lupus Foundation of America: Marijuana and Lupusaccessed May 18, 2026
  7. American College of Rheumatology: 2023 Guideline for SLE Management (executive summary)accessed May 18, 2026
  8. MedlinePlus: Systemic lupus erythematosusaccessed May 18, 2026